Niksan Pharmaceutical is topleading manufacturer, supplier, exporter and trader in Indian states and alsoin worlds other countries. Quetiapine isthe best product of Niksan Pharmaceutical which exporting as a form of API andfinished formulations.
Niksan Pharmaceutical providesAPI and finished formulation of Quetiapinein many Indian states like Maharashtra, Odisha, Uttar Pradesh, Delhi,Rajasthan, Madhya Pradesh, West Bengal, Bihar, Himachal Pradesh, AndhraPradesh, Tamil Nadu, Telangana, Kerala, Karnataka, Gujarat, Jammu &Kashmir, Chandigarh, Punjab, Uttarakhand, Chhattisgarh, Haryana, Assam and manyother Indian states.
Niksan Pharmaceutical is alsohuge exporter of the API and finished pharmaceutical products of Quetiapine in many countries for years.The countries where we exporting are India, Nepal, Japan, United Arab Emirates,Hong Kong, Taiwan, India, France , Canada, Bangladesh, Poland, Pakistan,Thailand, Netherlands, Turkey, Vietnam, Philippines, Iran, Canada Ukraine,Bolivia, Bangladesh, Philippines, Thailand, Saudi Arabia, Italy, Australia,Canada, United States, United Kingdom, Mexico, Indonesia and many othercountries.
Quetiapine is anantipsychotic medicine which is used to treatment of schizophrenia in adultsand children who are at least 13 years old.
Quetiapine is also usedto treatment of bipolar disorder in 10 year old children and adults.
SYNONYMS: Quetiapina, Qutiapine,Quetiapine, Quetiapinum
CAS NO: 111974-69-7
MOLECULAR MASS: 383.50 g/mol
STORAGE OF Quetiapine: Store it incool and dry place, away from moisture and direct light. Do not store this medicine in bathroom or anyhumidly place.
APPLICATIONS OF Quetiapine: Quetiapine is an anti-psychotic drug which is used to treatment of bipolar disorders, sudden episodes of mania or depression and mentalcondition. It is also use as sleeping drug.
HOWTO USE: Quetiapine is taken by mouthwithout food or light meal. Do not crush the tablet. Generally you can take 3tablets in one day.
HOW QUETIAPINE WORKS: Quetiapine works in human brain to treat schizophrenia.Quetiapine also improve your mood, thinking and behaviour.
CONTRAINDICATIONS: If you have a breast cancer and diabetes kindly avoid this medication. Ifyou have a low amount of potassium and magnesium in your blood do not take thismedication. If you have a slow heart beat and liver problems kindly avoid Quetiapine. Kindly avoid this medication if you areallergic to it.
PHARMACOKINETIKS OF Quetiapine: Quetiapine absorbed rapidly and well after oraladministration. Half life of Quetiapine is about 6 to 7 hours. Quetiapine ismainly metabolized in liver. Time of peak plasma concentration of Quetiapine is1.5 hour after oral administration. 73% excretion is done by urine and 20%excreted via feces.
SIDEEFFECTS OF Quetiapine: Somecommon side effects are upset stomach, nausea, vomiting, drowsiness, behaviourchanges, constipation and stomach pain. Other side effect of Quetiapine istiredness, headache, and trouble in sleeping, dry mouth, sore throat and weightgain.
PRECAUTION:Before using Quetiapine share your medical history with your doctor. Ifyou are allergic to Quetiapine kindly ask your doctor. This drug may make youdizzy so kindly avoid alcohol and cannabis. Do not drive.
CDSCO APPROVAL: Quetiapine(As fumarate) SR 400mg tablet (additional strength) is approved by CDSCO inIndia in 05.03.2007.
QuetiapineSR Tablets 50mg (additional strength) is approved by CDSCO in India in 10.04.2007
Quetiapinefumerate tablet is approved by CDSCO in India in 03.06.2002.
Quetiapinefumarate SR tablet is approved by CDSCO in India in 21.02.2008.
QuetiapineS.R tablet 200/300mg is approved by CDSCO in India in 01.08.2006.
FORMULATIONS AVAILABLE IN MARKET:
Quetiapine50 MG tablets
Quetiapine25 MG tablets
Quetiapine100 MG tablets
Quetiapine200 MG tablets
Quetiapine300 MG tablets
Quetiapine400 MG tablets
Quetiapine(As fumerate) SR 400mg tablets (additional strength)
QuetiapineSR Tablets 50mg (additional strength)
Note: Product protected by validpatents are not offered for sale in countries where such patents are stillvalid and its liability is at Buyers Risk.